Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Other Operating Expenses (2020 - 2025)

Biofrontera (BFRI) has 6 years of Other Operating Expenses data on record, last reported at $2.4 million in Q3 2025.

  • For Q3 2025, Other Operating Expenses fell 82.23% year-over-year to $2.4 million; the TTM value through Sep 2025 reached $39.3 million, up 119.37%, while the annual FY2024 figure was $36.2 million, 5.29% down from the prior year.
  • Other Operating Expenses reached $2.4 million in Q3 2025 per BFRI's latest filing, down from $6.8 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $34.5 million in Q3 2023 and bottomed at -$3.9 million in Q4 2023.
  • Average Other Operating Expenses over 5 years is $6.5 million, with a median of $4.1 million recorded in 2024.
  • The widest YoY moves for Other Operating Expenses: up 17524.49% in 2023, down 168.13% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at $1.9 million in 2021, then surged by 204.89% to $5.7 million in 2022, then crashed by 168.13% to -$3.9 million in 2023, then soared by 689.4% to $22.8 million in 2024, then plummeted by 89.63% to $2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $2.4 million in Q3 2025, $6.8 million in Q2 2025, and $7.4 million in Q1 2025.